Therapeutic targeting of BTK by its inhibitors in inflammatory CNS disorders or treatment of autoimmune diseases is an emerging strategy that holds huge potential and can support current treatments of several neurological disorders and bring new paradigms toward brain disease. The gene discussed is BTK; the disease is brain disorder.